Creative Biolabs Highlights Complementary Blood-Brain Barrier Models for CNS Drug Research

November 17 11:12 2026
Co-culture and 3D spheroid systems offer distinct ways to investigate barrier integrity, compound transport, and neurovascular interactions in preclinical CNS research.

New York, USA – November 17, 2026 – The blood-brain barrier (BBB) presents a major challenge in central nervous system (CNS) drug research, restricting the movement of many investigational compounds from the circulation into the brain. Creative Biolabs is highlighting two complementary human-cell-based research approaches—a brain endothelial cell, astrocyte, and pericyte co-culture model and a 3D BBB spheroid model—to help CNS research teams align model selection, experimental endpoints, and follow-up studies with their specific questions.

Why BBB Model Selection Matters

Conventional cell monolayers can support initial permeability investigations, but they do not fully represent the multicellular interactions of the neurovascular unit. Brain endothelial cells form the principal selective barrier, while astrocytes and pericytes contribute to barrier maintenance and regulation. Different in vitro configurations therefore offer different experimental perspectives rather than interchangeable predictions of in vivo drug delivery.

Creative Biolabs’ brain endothelial cell, astrocyte, and pericyte co-culture model supports investigation of key BBB cell interactions, barrier-related morphology, endothelial junctions, vascular permeability, and compound transport. The choice of analytical endpoints and controls should be defined for each study rather than assumed from the model name alone.

Adding a Three-Dimensional Perspective

The company also provides a 3D human BBB spheroid model comprising endothelial cells, astrocytes, and pericytes in a multicellular spheroid configuration. This format can be used to explore spatially organized cell interactions, compound distribution, and BBB-related responses through suitable imaging and functional analyses.

The formats serve different purposes. A barrier-focused co-culture system may help examine endothelial properties and permeability-related responses; spheroids can offer an additional perspective on multicellular organization and imaging-based observations. Neither system independently establishes human brain exposure or clinical efficacy.

Connecting Models With Fit-for-Purpose Measurements

Model selection is only one part of a useful BBB study. Depending on the research question and technical feasibility, project teams may discuss imaging, assessments of endothelial junctions, permeability-related measurements, and other appropriate functional readouts with Creative Biolabs. Specific methods—such as electrical-resistance testing, tracer-based paracellular permeability assays, or individual junction-marker analyses—should be confirmed with the scientific team before being included in a study plan.

For example, a CNS discovery programme may use a barrier-focused co-culture model to investigate permeability-related responses and a 3D spheroid model to examine spatially organised multicellular interactions. Depending on the research question, these systems may be used independently or as complementary approaches. Differences between their results can help guide follow-up experiments without being treated as definitive evidence of human brain penetration.

A useful BBB model should answer a defined research question. Matching model configuration, controls, and analytical endpoints can help make preclinical findings more interpretable while keeping the limitations of in vitro systems clear.

Explore Blood-Brain Barrier Research Models

Researchers investigating CNS drug transport, barrier integrity, or neurovascular interactions can explore Creative Biolabs’ BBB co-culture model and 3D BBB spheroid model. Project teams can contact Creative Biolabs to discuss target compounds, study objectives, preferred model formats, analytical requirements, and suitable preclinical research approaches.

All models and services described are intended for research use only and are not intended to establish clinical efficacy or independently predict human brain exposure.

About Creative Biolabs

Creative Biolabs provides customized biotechnology research services, including cell-based models and analytical solutions, to support discovery and preclinical research programs worldwide.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com/3d-biology

  Categories: